2023
DOI: 10.1016/j.wneu.2023.07.130
|View full text |Cite
|
Sign up to set email alerts
|

Bypass Surgery for Adult-Onset Hemorrhagic Moyamoya Disease: Analysis Classified by Site of Initial Bleeding

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 25 publications
0
0
0
Order By: Relevance
“…In hemorrhagic MMD, rebleeding is a factor that significantly worsens the prognosis, and its prevention is a primary concern. The Japanese Adult Moyamoya trial, a multicenter, prospective, randomized controlled trial, demonstrated that bypass surgery effectively prevented rebleeding in patients with specific backgrounds [ 6 , 19 ]. The inclusion criteria for the study included age between 16 and 65 years and a modified Rankin scale score of 0 to 2, indicating independence.…”
Section: Discussionmentioning
confidence: 99%
“…In hemorrhagic MMD, rebleeding is a factor that significantly worsens the prognosis, and its prevention is a primary concern. The Japanese Adult Moyamoya trial, a multicenter, prospective, randomized controlled trial, demonstrated that bypass surgery effectively prevented rebleeding in patients with specific backgrounds [ 6 , 19 ]. The inclusion criteria for the study included age between 16 and 65 years and a modified Rankin scale score of 0 to 2, indicating independence.…”
Section: Discussionmentioning
confidence: 99%